img

Global mTOR Inhibitors Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global mTOR Inhibitors Market Insights, Forecast to 2034

mTOR inhibitors are a class of drugs that inhibit the mechanistic target of rapamycin (mTOR).
Global mTOR Inhibitors market is expected to reach to US$ 6284.6 million in 2024, with a positive growth of %, compared with US$ 6008.2 million in 2022. Backed with the increasing demand from downstream industries, mTOR Inhibitors industry is evaluated to reach US$ 8470.2 million in 2029. The CAGR will be 5.1% during 2024 to 2029.
Mammalian target of rapamycin (mTOR) inhibitors block the activity of the mammalian target of rapamycin. Mammalian target of rapamycin is a protein kinase, which regulates growth factors that stimulate cell growth and angiogenesis. In certain cancers the mTOR pathway is more active.
Report Covers
This report presents an overview of global mTOR Inhibitors market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global mTOR Inhibitors market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


LC Laboratories
Teva Pharmaceutical Industries Ltd.
Exelixis
Novartis Oncology
Pfizer
GSK
Segment by Type
Rapamune
Torisel
Afinitor
Zortress

Segment by Application


Tumor Treatment
Kidney Transplant
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ mTOR Inhibitors plant distribution, commercial date of mTOR Inhibitors, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, mTOR Inhibitors introduction, etc. mTOR Inhibitors Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of mTOR Inhibitors
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 mTOR Inhibitors Product Introduction
1.2 Market by Type
1.2.1 Global mTOR Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Rapamune
1.2.3 Torisel
1.2.4 Afinitor
1.2.5 Zortress
1.3 Market by Application
1.3.1 Global mTOR Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Tumor Treatment
1.3.3 Kidney Transplant
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global mTOR Inhibitors Sales Estimates and Forecasts 2018-2029
2.2 Global mTOR Inhibitors Revenue by Region
2.2.1 Global mTOR Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global mTOR Inhibitors Revenue by Region (2018-2024)
2.2.3 Global mTOR Inhibitors Revenue by Region (2024-2029)
2.2.4 Global mTOR Inhibitors Revenue Market Share by Region (2018-2029)
2.3 Global mTOR Inhibitors Sales Estimates and Forecasts 2018-2029
2.4 Global mTOR Inhibitors Sales by Region
2.4.1 Global mTOR Inhibitors Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global mTOR Inhibitors Sales by Region (2018-2024)
2.4.3 Global mTOR Inhibitors Sales by Region (2024-2029)
2.4.4 Global mTOR Inhibitors Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global mTOR Inhibitors Sales by Manufacturers
3.1.1 Global mTOR Inhibitors Sales by Manufacturers (2018-2024)
3.1.2 Global mTOR Inhibitors Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of mTOR Inhibitors in 2022
3.2 Global mTOR Inhibitors Revenue by Manufacturers
3.2.1 Global mTOR Inhibitors Revenue by Manufacturers (2018-2024)
3.2.2 Global mTOR Inhibitors Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by mTOR Inhibitors Revenue in 2022
3.3 Global Key Players of mTOR Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global mTOR Inhibitors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global mTOR Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of mTOR Inhibitors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of mTOR Inhibitors, Product Offered and Application
3.8 Global Key Manufacturers of mTOR Inhibitors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global mTOR Inhibitors Sales by Type
4.1.1 Global mTOR Inhibitors Historical Sales by Type (2018-2024)
4.1.2 Global mTOR Inhibitors Forecasted Sales by Type (2024-2029)
4.1.3 Global mTOR Inhibitors Sales Market Share by Type (2018-2029)
4.2 Global mTOR Inhibitors Revenue by Type
4.2.1 Global mTOR Inhibitors Historical Revenue by Type (2018-2024)
4.2.2 Global mTOR Inhibitors Forecasted Revenue by Type (2024-2029)
4.2.3 Global mTOR Inhibitors Revenue Market Share by Type (2018-2029)
4.3 Global mTOR Inhibitors Price by Type
4.3.1 Global mTOR Inhibitors Price by Type (2018-2024)
4.3.2 Global mTOR Inhibitors Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global mTOR Inhibitors Sales by Application
5.1.1 Global mTOR Inhibitors Historical Sales by Application (2018-2024)
5.1.2 Global mTOR Inhibitors Forecasted Sales by Application (2024-2029)
5.1.3 Global mTOR Inhibitors Sales Market Share by Application (2018-2029)
5.2 Global mTOR Inhibitors Revenue by Application
5.2.1 Global mTOR Inhibitors Historical Revenue by Application (2018-2024)
5.2.2 Global mTOR Inhibitors Forecasted Revenue by Application (2024-2029)
5.2.3 Global mTOR Inhibitors Revenue Market Share by Application (2018-2029)
5.3 Global mTOR Inhibitors Price by Application
5.3.1 Global mTOR Inhibitors Price by Application (2018-2024)
5.3.2 Global mTOR Inhibitors Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada mTOR Inhibitors Market Size by Type
6.1.1 US & Canada mTOR Inhibitors Sales by Type (2018-2029)
6.1.2 US & Canada mTOR Inhibitors Revenue by Type (2018-2029)
6.2 US & Canada mTOR Inhibitors Market Size by Application
6.2.1 US & Canada mTOR Inhibitors Sales by Application (2018-2029)
6.2.2 US & Canada mTOR Inhibitors Revenue by Application (2018-2029)
6.3 US & Canada mTOR Inhibitors Market Size by Country
6.3.1 US & Canada mTOR Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada mTOR Inhibitors Sales by Country (2018-2029)
6.3.3 US & Canada mTOR Inhibitors Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe mTOR Inhibitors Market Size by Type
7.1.1 Europe mTOR Inhibitors Sales by Type (2018-2029)
7.1.2 Europe mTOR Inhibitors Revenue by Type (2018-2029)
7.2 Europe mTOR Inhibitors Market Size by Application
7.2.1 Europe mTOR Inhibitors Sales by Application (2018-2029)
7.2.2 Europe mTOR Inhibitors Revenue by Application (2018-2029)
7.3 Europe mTOR Inhibitors Market Size by Country
7.3.1 Europe mTOR Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe mTOR Inhibitors Sales by Country (2018-2029)
7.3.3 Europe mTOR Inhibitors Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China mTOR Inhibitors Market Size
8.1.1 China mTOR Inhibitors Sales (2018-2029)
8.1.2 China mTOR Inhibitors Revenue (2018-2029)
8.2 China mTOR Inhibitors Market Size by Application
8.2.1 China mTOR Inhibitors Sales by Application (2018-2029)
8.2.2 China mTOR Inhibitors Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia mTOR Inhibitors Market Size by Type
9.1.1 Asia mTOR Inhibitors Sales by Type (2018-2029)
9.1.2 Asia mTOR Inhibitors Revenue by Type (2018-2029)
9.2 Asia mTOR Inhibitors Market Size by Application
9.2.1 Asia mTOR Inhibitors Sales by Application (2018-2029)
9.2.2 Asia mTOR Inhibitors Revenue by Application (2018-2029)
9.3 Asia mTOR Inhibitors Sales by Region
9.3.1 Asia mTOR Inhibitors Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia mTOR Inhibitors Revenue by Region (2018-2029)
9.3.3 Asia mTOR Inhibitors Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America mTOR Inhibitors Market Size by Type
10.1.1 Middle East, Africa and Latin America mTOR Inhibitors Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America mTOR Inhibitors Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America mTOR Inhibitors Market Size by Application
10.2.1 Middle East, Africa and Latin America mTOR Inhibitors Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America mTOR Inhibitors Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America mTOR Inhibitors Sales by Country
10.3.1 Middle East, Africa and Latin America mTOR Inhibitors Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America mTOR Inhibitors Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America mTOR Inhibitors Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 LC Laboratories
11.1.1 LC Laboratories Company Information
11.1.2 LC Laboratories Overview
11.1.3 LC Laboratories mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 LC Laboratories mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 LC Laboratories Recent Developments
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Information
11.2.2 Teva Pharmaceutical Industries Ltd. Overview
11.2.3 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments
11.3 Exelixis
11.3.1 Exelixis Company Information
11.3.2 Exelixis Overview
11.3.3 Exelixis mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Exelixis mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Exelixis Recent Developments
11.4 Novartis Oncology
11.4.1 Novartis Oncology Company Information
11.4.2 Novartis Oncology Overview
11.4.3 Novartis Oncology mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Novartis Oncology mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Novartis Oncology Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pfizer mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 GSK
11.6.1 GSK Company Information
11.6.2 GSK Overview
11.6.3 GSK mTOR Inhibitors Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 GSK mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GSK Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 mTOR Inhibitors Industry Chain Analysis
12.2 mTOR Inhibitors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 mTOR Inhibitors Production Mode & Process
12.4 mTOR Inhibitors Sales and Marketing
12.4.1 mTOR Inhibitors Sales Channels
12.4.2 mTOR Inhibitors Distributors
12.5 mTOR Inhibitors Customers
13 Market Dynamics
13.1 mTOR Inhibitors Industry Trends
13.2 mTOR Inhibitors Market Drivers
13.3 mTOR Inhibitors Market Challenges
13.4 mTOR Inhibitors Market Restraints
14 Key Findings in The Global mTOR Inhibitors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global mTOR Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Rapamune
Table 3. Major Manufacturers of Torisel
Table 4. Major Manufacturers of Afinitor
Table 5. Major Manufacturers of Zortress
Table 6. Global mTOR Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global mTOR Inhibitors Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global mTOR Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global mTOR Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global mTOR Inhibitors Revenue Market Share by Region (2018-2024)
Table 11. Global mTOR Inhibitors Revenue Market Share by Region (2024-2029)
Table 12. Global mTOR Inhibitors Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global mTOR Inhibitors Sales by Region (2018-2024) & (Kg)
Table 14. Global mTOR Inhibitors Sales by Region (2024-2029) & (Kg)
Table 15. Global mTOR Inhibitors Sales Market Share by Region (2018-2024)
Table 16. Global mTOR Inhibitors Sales Market Share by Region (2024-2029)
Table 17. Global mTOR Inhibitors Sales by Manufacturers (2018-2024) & (Kg)
Table 18. Global mTOR Inhibitors Sales Share by Manufacturers (2018-2024)
Table 19. Global mTOR Inhibitors Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global mTOR Inhibitors Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of mTOR Inhibitors, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. mTOR Inhibitors Price by Manufacturers 2018-2024 (USD/mg)
Table 23. Global mTOR Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global mTOR Inhibitors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mTOR Inhibitors as of 2022)
Table 25. Global Key Manufacturers of mTOR Inhibitors, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of mTOR Inhibitors, Product Offered and Application
Table 27. Global Key Manufacturers of mTOR Inhibitors, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 30. Global mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 31. Global mTOR Inhibitors Sales Share by Type (2018-2024)
Table 32. Global mTOR Inhibitors Sales Share by Type (2024-2029)
Table 33. Global mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global mTOR Inhibitors Revenue Share by Type (2018-2024)
Table 36. Global mTOR Inhibitors Revenue Share by Type (2024-2029)
Table 37. mTOR Inhibitors Price by Type (2018-2024) & (USD/mg)
Table 38. Global mTOR Inhibitors Price Forecast by Type (2024-2029) & (USD/mg)
Table 39. Global mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 40. Global mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 41. Global mTOR Inhibitors Sales Share by Application (2018-2024)
Table 42. Global mTOR Inhibitors Sales Share by Application (2024-2029)
Table 43. Global mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global mTOR Inhibitors Revenue Share by Application (2018-2024)
Table 46. Global mTOR Inhibitors Revenue Share by Application (2024-2029)
Table 47. mTOR Inhibitors Price by Application (2018-2024) & (USD/mg)
Table 48. Global mTOR Inhibitors Price Forecast by Application (2024-2029) & (USD/mg)
Table 49. US & Canada mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 50. US & Canada mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 51. US & Canada mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 54. US & Canada mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 55. US & Canada mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada mTOR Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada mTOR Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada mTOR Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada mTOR Inhibitors Sales by Country (2018-2024) & (Kg)
Table 61. US & Canada mTOR Inhibitors Sales by Country (2024-2029) & (Kg)
Table 62. Europe mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 63. Europe mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 64. Europe mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 67. Europe mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 68. Europe mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe mTOR Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe mTOR Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe mTOR Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe mTOR Inhibitors Sales by Country (2018-2024) & (Kg)
Table 74. Europe mTOR Inhibitors Sales by Country (2024-2029) & (Kg)
Table 75. China mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 76. China mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 77. China mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 78. China mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 79. China mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 80. China mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 81. China mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 82. China mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 84. Asia mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 85. Asia mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 88. Asia mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 89. Asia mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia mTOR Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia mTOR Inhibitors Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia mTOR Inhibitors Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia mTOR Inhibitors Sales by Region (2018-2024) & (Kg)
Table 95. Asia mTOR Inhibitors Sales by Region (2024-2029) & (Kg)
Table 96. Middle East, Africa and Latin America mTOR Inhibitors Sales by Type (2018-2024) & (Kg)
Table 97. Middle East, Africa and Latin America mTOR Inhibitors Sales by Type (2024-2029) & (Kg)
Table 98. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America mTOR Inhibitors Sales by Application (2018-2024) & (Kg)
Table 101. Middle East, Africa and Latin America mTOR Inhibitors Sales by Application (2024-2029) & (Kg)
Table 102. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America mTOR Inhibitors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America mTOR Inhibitors Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America mTOR Inhibitors Sales by Country (2018-2024) & (Kg)
Table 108. Middle East, Africa and Latin America mTOR Inhibitors Sales by Country (2024-2029) & (Kg)
Table 109. LC Laboratories Company Information
Table 110. LC Laboratories Description and Major Businesses
Table 111. LC Laboratories mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 112. LC Laboratories mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. LC Laboratories Recent Developments
Table 114. Teva Pharmaceutical Industries Ltd. Company Information
Table 115. Teva Pharmaceutical Industries Ltd. Description and Major Businesses
Table 116. Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 117. Teva Pharmaceutical Industries Ltd. mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 119. Exelixis Company Information
Table 120. Exelixis Description and Major Businesses
Table 121. Exelixis mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 122. Exelixis mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Exelixis Recent Developments
Table 124. Novartis Oncology Company Information
Table 125. Novartis Oncology Description and Major Businesses
Table 126. Novartis Oncology mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 127. Novartis Oncology mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Novartis Oncology Recent Developments
Table 129. Pfizer Company Information
Table 130. Pfizer Description and Major Businesses
Table 131. Pfizer mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 132. Pfizer mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Pfizer Recent Developments
Table 134. GSK Company Information
Table 135. GSK Description and Major Businesses
Table 136. GSK mTOR Inhibitors Sales (Kg), Revenue (US$ Million), Price (USD/mg) and Gross Margin (2018-2024)
Table 137. GSK mTOR Inhibitors Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. GSK Recent Developments
Table 139. Key Raw Materials Lists
Table 140. Raw Materials Key Suppliers Lists
Table 141. mTOR Inhibitors Distributors List
Table 142. mTOR Inhibitors Customers List
Table 143. mTOR Inhibitors Market Trends
Table 144. mTOR Inhibitors Market Drivers
Table 145. mTOR Inhibitors Market Challenges
Table 146. mTOR Inhibitors Market Restraints
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. mTOR Inhibitors Product Picture
Figure 2. Global mTOR Inhibitors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global mTOR Inhibitors Market Share by Type in 2022 & 2029
Figure 4. Rapamune Product Picture
Figure 5. Torisel Product Picture
Figure 6. Afinitor Product Picture
Figure 7. Zortress Product Picture
Figure 8. Global mTOR Inhibitors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global mTOR Inhibitors Market Share by Application in 2022 & 2029
Figure 10. Tumor Treatment
Figure 11. Kidney Transplant
Figure 12. Others
Figure 13. mTOR Inhibitors Report Years Considered
Figure 14. Global mTOR Inhibitors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global mTOR Inhibitors Revenue 2018-2029 (US$ Million)
Figure 16. Global mTOR Inhibitors Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global mTOR Inhibitors Revenue Market Share by Region (2018-2029)
Figure 18. Global mTOR Inhibitors Sales 2018-2029 ((Kg)
Figure 19. Global mTOR Inhibitors Sales Market Share by Region (2018-2029)
Figure 20. US & Canada mTOR Inhibitors Sales YoY (2018-2029) & (Kg)
Figure 21. US & Canada mTOR Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe mTOR Inhibitors Sales YoY (2018-2029) & (Kg)
Figure 23. Europe mTOR Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China mTOR Inhibitors Sales YoY (2018-2029) & (Kg)
Figure 25. China mTOR Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) mTOR Inhibitors Sales YoY (2018-2029) & (Kg)
Figure 27. Asia (excluding China) mTOR Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America mTOR Inhibitors Sales YoY (2018-2029) & (Kg)
Figure 29. Middle East, Africa and Latin America mTOR Inhibitors Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The mTOR Inhibitors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of mTOR Inhibitors in the World: Market Share by mTOR Inhibitors Revenue in 2022
Figure 32. Global mTOR Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 34. Global mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 35. Global mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 36. Global mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 38. US & Canada mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 40. US & Canada mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada mTOR Inhibitors Revenue Share by Country (2018-2029)
Figure 42. US & Canada mTOR Inhibitors Sales Share by Country (2018-2029)
Figure 43. U.S. mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 44. Canada mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 45. Mexico mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 46. Europe mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 47. Europe mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 48. Europe mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 49. Europe mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 50. Europe mTOR Inhibitors Revenue Share by Country (2018-2029)
Figure 51. Europe mTOR Inhibitors Sales Share by Country (2018-2029)
Figure 52. Germany mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 53. France mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 54. UK mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 55. Italy mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 56. Russia mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 57. China mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 58. China mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 59. China mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 60. China mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 61. Asia mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 62. Asia mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 63. Asia mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 64. Asia mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 65. Asia mTOR Inhibitors Revenue Share by Region (2018-2029)
Figure 66. Asia mTOR Inhibitors Sales Share by Region (2018-2029)
Figure 67. Japan mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 71. India mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America mTOR Inhibitors Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America mTOR Inhibitors Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America mTOR Inhibitors Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America mTOR Inhibitors Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America mTOR Inhibitors Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America mTOR Inhibitors Sales Share by Country (2018-2029)
Figure 78. Brazil mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 81. Israel mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries mTOR Inhibitors Revenue (2018-2029) & (US$ Million)
Figure 83. mTOR Inhibitors Value Chain
Figure 84. mTOR Inhibitors Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries